Abstract

Invasive breast carcinoma of no special type (IBC of NST) is a group of malignant epithelial neoplasms of the breast glands with the highest incidence of cancer in women. Tumor infiltrating lymphocytes (TIL) CD8+ is considered a group of T cells that play a role in the reactivity of specific immunity against cancer cells. TIL CD8+ group is a component that plays a role in specific adaptive immunity. TIL CD8+ infiltration in stromal tumor is related to a favorable prognosis and can predict the therapy outcome in patients. This study aims to determine the relationship between TIL CD8+ stromal and intratumoral with grading, ER and PR expression in the IBC of NST. The design of this study is analytical observational using 44 paraffin block samples in patients with IBC of NST at the Anatomical Pathology Department of Dr. Saiful Anwar Malang General Hospital by measuring TIL CD8+ expression on stromal and intratumoral, associated with grading and ER and PR expression. The results of this research showed that there is no significant relationship between histopathological grading with TIL (TIL CD8+ stromal p = 0.264, TIL CD8+ intratumoral p = 0.820), ER expression with TIL (TIL CD8+ stromal p = 0,297, TIL CD8+ intratumoral p = 0,145) and PR Expressions with TIL (TIL CD8+ stromal p = 0.240, TIL CD8+ intratumoral p = 0,003). In conclusion, there is no relationship between TIL CD8+ stromal and intratumoral with grading, expression of ER and PR in patients with IBC of NST.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.